Karin Hoelzer’s Post

As we are getting ready for Clinical Trials Day... Here's just one of the countless reasons we should celebrate everyone who plays a critical role in clinical trials! 🙌 ACRP - Association of Clinical Research Professionals #patients #clinicaloperations #medicalaffairs #clinicalresearchers #ClinicalTrialsDay #CTD2024 #clinicaltrials #QoL #QualityofLife

With less than 2 weeks to go there is still time to register for the #WODC conference 23-25 April in Boston, MA. 👋 Our mighty team will be on stage 24 April to discuss, ‘Patient Recruitment for Neurodegenerative and Neuromuscular #ClinicalTrials.’ 🧠 Attendees can hear our Director of Clinical Trial Operations, Jytte van Huijstee, alongside our Patient Navigator, Madeleine Carrier PharmD and Patient Advocate Partner, Terri Ellsworth, as they dissect the benefits of our platform to involve all stakeholders throughout the clinical trial funnel, and how our human-led approach including our Patient Navigators, ensures accurate communication along the full funnel. Another of our experts at #WorldOrphanDrugCongress is Dennis Akkaya our Chief Commerical Officer, who will be at our booth 532 to discuss how the myTomorrows approach is breaking barriers in the clinical trial funnel for all stakeholders from patients and advocacy groups through to BioPharma. Book a. meeting with Dennis here: https://lnkd.in/dPRcrnXd Use code SPK50 for 50% off when registering https://lnkd.in/edzz8riT ▶️ Our roundtable is at 14:15 on Wednesday 24 April. Patient Recruitment for Neurodegenerative and Neuromuscular Clinical Trials. - How to reach more patients: clinical trial agnostic and clinical trial specific approaches. - A Patient Navigators role in the Clinical Trial journey of patients and physicians - Understand how to involve all stakeholders through our platform #RareDisease #OrphanDrug #WODC2024

As we continue our weeklong celebration of Clinical Trials Day, we're shining a light on our amazing trial participants. These volunteers are true trailblazers, and clinical trials wouldn't be possible without their dedication. Watch the video below to meet some of our incredible past research volunteers and discover why they chose to participate in clinical research with MAC. You can also read more about Clinical Trials Day in our article here: https://lnkd.in/ew7dBKns #ClinicalTrialsDay #CTD2024 #clinicaltrials #clinicalresearch #cro

After watching the The White House Clinical Trials Forum and as someone who has witnessed the impact of clinical trials firsthand, I feel compelled to share my thoughts on this crucial topic. Our colleague, Monica's brave battle with cholangiocarcinoma has opened my eyes to the urgent need for more accessible clinical trials, especially for rare and aggressive cancers. Clinical trials are often the last beacon of hope for patients facing life-threatening illnesses, yet many are unaware of their existence or face significant barriers to participation. We need to do better in educating both patients and doctors about available trials and their potential benefits. I'm encouraged by the recent FDA release of the Diverse Access to Enrollment Action Plan, which aims to increase diversity in clinical trial participation. This is a step in the right direction, but we must go further. We need to ease eligibility criteria, rethink the use of placebos in certain cases, and make trials more patient-centric. Organizations like the Cholangiocarcinoma Foundation, recently seen on the panel at the White House Clinical Trials Forum, are doing incredible work in advocating for patients and pushing for more accessible trials. Their efforts are crucial, especially for lesser-known cancers that often receive less attention and funding. >>link to White House Clinical Trials Forum from June 26,2024 https://lnkd.in/d6BjtDGx >>link to the Diverse Access to Enrollment Action https://lnkd.in/dzzQu4JH #ClinicalTrials #PatientAdvocacy #CholangiocarcinomaAwareness #AccessibleHealthcare

SMS Clinical Research Celebrates Enrolling the 100th Patient in UTI Vaccine Study! We are thrilled to announce that we have enrolled our 100th patient in our UTI vaccine study! This achievement is a testament to our team's relentless dedication and hard work. We extend our heartfelt gratitude to our incredible team, participants, and sponsors for their unwavering support. Join us in celebrating this significant milestone and learn more about how SMS Clinical Research is paving the way for innovative clinical trials. Discover more about our groundbreaking research and how we can support your clinical trial needs: Clinical Trials in Mesquite, TX | SMS Clinical Research #UTIVaccine #JoinUs #HealthcareInnovation #BeAPartOfTheSolution #Mesquite #SMSClinicalResearch #HealthyLiving #ClinicalTrial #PatientCare #MedicalResearch #ClinicalTrials #Covid19 #HealthScience #ClinicalStudy #ResearchTrial #PatientCare #HealthCare #Treatment #Eczema

We are delighted to announce one of the biggest milestones in our mission to transform chronic wound care — our CLEANVLU Phase IIa clinical trial report, which demonstrates proof-of-concept and safety of Aurase Wound Gel in humans, has now been published in International Wound Journal. Aurase Wound Gel aims to provide, for the first time, a safe, pain-free, and effective treatment for millions of people suffering from chronic wounds worldwide, and we are incredibly excited to be progressing this product through further Phase II studies. Our Chairman of the Board, Andy Weymann, MD, MBA, comments: “The peer-review publication of our Phase IIa data not only provides important validation to enable further Phase II studies, but also highlights the clinical potential of Aurase Wound Gel to treat millions of patients globally safely and effectively, addressing an urgent and unmet medical need. With this excellent data we are now fundraising to support the next phase of SolasCure’s clinical and product development.” Learn more here: https://lnkd.in/d4EbWtYd #WoundCare #ChronicWounds #ClinicalTrials #HealthCare

"Clinical trial participants should be national heroes" Kevin Craig, Michael Gold and Dan Karlin joined me to discuss building patient trust in clinical trials at CNS Summit A few salient points stood out: 1. Trust in pharma is at an all time low. While we can't do anything about misaligned incentives, there is plenty that sponsors and sites can be intentional about. 2. It starts with honesty. Especially given the hype in psychedelic research, it's important to be clear about expectations. One site we spoke with has even transitioned to calling patients "volunteers". 3. Patient recruitment is the tip of the spear. This starts with response rates and flows through to how medical information is collected, shared, and protected 4. The site experience drives so much. First impressions at a clinic from the waiting room to staff organization can put patients at ease or on edge Had a blast moderating this panel and can't wait to reconnect with the CNS community next year

We are proud to sponsor Cure SMA’s Annual International Spinal Muscular Atrophy (#SMA) Research & Clinical Care Meeting, the largest gathering of academic researchers, government agencies, #biotech industry representatives and clinicians dedicated to SMA research and care. Held from 5-7 June in Austin, Texas, goals of this year’s meeting include open communication of early scientific data, cross-disciplinary knowledge sharing to accelerate the pace of research and the promotion of #collaboration between the SMA community and researchers. Vera K., our Director of Clinical Development, will present the latest updates from the podium of the Research and Clinical Care Symposium on the ongoing Phase 2 #ClinicalTrial of NMD670, our lead CIC-1 ion channel skeletal muscle-activating therapy, in ‘Study Design and Status Update on the SYNAPSE-SMA Phase 2 Trial of NMD670 in Ambulatory Adults with Spinal Muscular Atrophy’ on 7 June from 11:00-11:20 CDT. NMD Pharma will also be presenting two abstracts detailing the mechanism of action of the skeletal-muscle targeted oral therapy NMD670 at the #2024SMACongress. The abstracts, which include a scientific poster and a ‘family friendly’ research poster, can be viewed from 5 June through 7 June at the meeting. Members of the NMD Pharma team, Dan Brennan, SVP, Corporate and Commercial Strategy, and Caitlin Cornwall, Associate Director of Clinical Operations, will also attend the meeting. If you are interested in learning about our novel muscle-targeted approach the treatment of SMA, please reach out to contact@nmdpharma.com to set up a meeting with them. For more information: https://lnkd.in/dJTQQm8v #NMDPharma #CureSMA #Conference #NeuromuscularDisease #Innovation

Arizona Clinical Trials Featured on Tucson Morning Blend! Our CEO, Dr. Anita Kohli, recently discussed the innovative research we’re conducting to combat the flu virus. Arizona Clinical Trials is at the forefront of evaluating investigational medications that could transform flu prevention and treatment. As healthcare providers, staying informed about these advancements is crucial to shaping the future of patient care. We’re proud to lead these efforts in Arizona, advancing medical science and offering new hope in flu management. Let’s continue driving innovation and improving outcomes together. https://lnkd.in/gHMX8wGg #ClinicalTrials #FluResearch #HealthcareInnovation #MedicalAdvances #ProviderPerspective #PatientCare #ArizonaScience #ArizonaClinicalTrials Anita Kohli Naim Alkhouri, MD, FAASLD Richard Manch Ann Moore Yessica Sachdeva Tessa Janovsky Rida Nadeem, MD, MSPH Angie Coste Esteban Rafael Lugo Morales Reichard R. Chelsea Ann Mihaylo Hum, PMP Kelly Carey Aileen Tammany Mazen Noureddin, MD, MHSc American Association for the Study of Liver Diseases (AASLD) Fatty Liver Alliance Fortrea Syneos Health IQVIA Medpace Madrigal Pharmaceuticals Inventiva Pharma AbbVie Gilead Sciences Echosens Summit Clinical Research Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter

Today, kicks off our 4th annual Lupus Clinical Investigators Network (LuCIN) Community Meeting, hosted by #LupusTherapeutics, the clinical affiliate of the Lupus Research Alliance. This annual meeting brings people with #lupus together with thought leaders, clinical investigators, study coordinators, research & industry partners to discuss the progress and advancements being made in #LupusClinicalResearch and treatment, and the importance of health equity and access in #lupus clinical trials. Learn more about LuCIN at https://bit.ly/LuCIN2024 #LuCINCommunity #LupusAwarenessMonth